Centralized Pan-Asian Survey on the Under Treatment of Hypercholesterolemia
NCT00687492 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8000
Last updated 2010-12-02
Summary
The survey will try to establish the proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the third NCEP ATP guidelines, overall and by country.
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Park Jeong Euy · Sungkyunkwan University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-05-31
- Primary Completion
- 2008-12-31
- Completion
- 2008-12-31
Countries
- China
- Indonesia
- Malaysia
- Philippines
- South Korea
- Taiwan
- Thailand
- Vietnam
Study Locations
More Related Trials
-
Korean Rosuvastatin Effectiveness Study in Nondiabetic Metabolic Syndrome
NCT00335699 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Asian Patients With Hypercholesterolaemia in the UK - Rosuvastatin 5mg Versus Atorvastatin 10mg
NCT00427960 ·Status: TERMINATED ·Phase: PHASE4
-
Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
NCT05850091 ·Status: RECRUITING ·Phase: PHASE4
-
Multicenter, Prospective, Non-interventional, Observational Study to Confirm the Long-term Efficacy and Safety of Rosuampin Tab. in Patients With Hypertension and Hypercholesterolemia
NCT06293261 ·Status: COMPLETED
-
Real-life EValuation Of High Dose RosUvastatin in High Risk Patients After TitraTION
NCT00526721 ·Status: COMPLETED
-
Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE)
NCT00574782 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of AZD0780 in Participants With Dyslipidaemia
NCT06834932 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease
NCT00329160 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease
NCT00235950 ·Status: COMPLETED ·Phase: PHASE4
-
Rosuvastatin Effect on Serial Echocardiographic Measurement of Coronary Flow Velocity Reserve
NCT01490398 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
NCT02532309 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study To Evaluate the Effect of Rosuvastatin On Intravascular Ultrasound-Derived Coronary Atheroma Burden (ASTEROID)
NCT00240318 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Rosuvastatin on Coronary Flow Reserve in Hypertensive Patients With Cardiovascular Risk
NCT02482207 ·Status: COMPLETED ·Phase: PHASE4
-
Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
NCT00653445 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Patients Treated With HMG-CoA Reductase Inhibitors to Reach Cholesterol Target Values
NCT01483950 ·Status: COMPLETED
-
Effects in The ApoB/ApoA-I Ratio Using Rosuvastatin and Atorvastatin in Patients With Acute Coronary Syndrome
NCT00296387 ·Status: COMPLETED ·Phase: PHASE3
-
Statin Monotherapy and Rosuzet Tab.(Rosuvastatin/Ezetimibe) Administration in Patients With Dyslipidemia in Korea
NCT04829149 ·Status: COMPLETED
-
Rosuvastatin Efficacy and Safety Evaluation in Hypercholesterolaemic Patients
NCT00695539 ·Status: COMPLETED
-
Efficacy and Safety of Combination of Rosuvastatin and Ezetimibe in Patients With Primary Hypercholesterolemia
NCT03571087 ·Status: COMPLETED ·Phase: PHASE3
-
Niacin/Laropiprant Tablet for South and Southeast Asians With Low High-Density Lipoprotein Cholesterol (LDL-C) at Risk for Cardiovascular Disease (MK-0524A-108)
NCT01414166 ·Status: TERMINATED ·Phase: PHASE3
-
Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan
NCT03872232 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Efficacy and Safety of Co-administrated Ezetimibe/Rosuvastatin and Telmisartan in Patients With Essential Hypertension and Primary Hypercholesterolemia
NCT04659070 ·Status: UNKNOWN ·Phase: PHASE3
-
To Investigate the Effect of Rosiglitazone and Ramipril on Pre-clinical Vasculopathy in Diabetes and IGT Patients
NCT00489229 ·Status: COMPLETED ·Phase: PHASE3
-
Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
NCT00239330 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Efficacy and Safety of Rosuvastatin 5 mg Versus Pravastatin 40 mg and Atorvastatin 10 mg in Type IIa and IIb Hypercholesterolaemic Patients
NCT00631189 ·Status: COMPLETED ·Phase: PHASE4